Asthma–COPD overlap 2015: now we are six
PG Gibson, VM McDonald - Thorax, 2015 - thorax.bmj.com
Background The overlap between asthma and COPD is increasingly recognised. This
review examines the new insights, treatment and remaining knowledge gaps for asthma …
review examines the new insights, treatment and remaining knowledge gaps for asthma …
[HTML][HTML] COPD phenotypes and machine learning cluster analysis: a systematic review and future research agenda
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a highly heterogeneous
condition projected to become the third leading cause of death worldwide by 2030. To better …
condition projected to become the third leading cause of death worldwide by 2030. To better …
Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention–Update 2016
Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …
Inhaled corticosteroid use and the risk of pneumonia and COPD exacerbations in the UPLIFT study
Rationale Unlike many other COPD studies, the 4-year UPLIFT trial permitted inhaled
corticosteroid (ICS) use during run-in and treatment phases. This provided the opportunity to …
corticosteroid (ICS) use during run-in and treatment phases. This provided the opportunity to …
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis
BF Hartley, NC Barnes, S Lettis, CH Compton… - Respiratory …, 2020 - Springer
Background Patients with chronic obstructive pulmonary disease (COPD) are at risk of
exacerbations and pneumonia; how the risk factors interact is unclear. Methods This post …
exacerbations and pneumonia; how the risk factors interact is unclear. Methods This post …
Impact of chronic obstructive pulmonary disease, lung infection, and/or inhaled corticosteroids use on potential risk of lung cancer
B Patel, R Priefer - Life Sciences, 2022 - Elsevier
Chronic obstructive pulmonary disease is the 3rd leading cause of death worldwide. It not
only affects current and former smokers, but non-smokers as well. Chronic inflammatory …
only affects current and former smokers, but non-smokers as well. Chronic inflammatory …
Pharmacological and non-pharmacological management of COPD; limitations and future prospects: a review of current literature
Objective This article aimed to summarize the pharmacological and non-pharmacological
management of COPD and limitations and prospects of the currently available …
management of COPD and limitations and prospects of the currently available …
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
N Hizawa - International Journal of Chronic Obstructive Pulmonary …, 2015 - Taylor & Francis
In the combined use of bronchodilators of different classes, ie, long-acting β2-agonists
(LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both …
(LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both …
Fixed-dose combination inhalers
M Cazzola, MG Matera - Pharmacology and Therapeutics of Asthma and …, 2017 - Springer
In asthma and chronic obstructive pulmonary disease (COPD), an important step in
simplifying management and improving adherence with prescribed therapy is to reduce the …
simplifying management and improving adherence with prescribed therapy is to reduce the …
Advancements and challenges in the management of pneumonia in elderly patients with COPD
S Ocrospoma, A Anzueto… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Chronic Obstructive Pulmonary Disease (COPD) significantly
predisposes the elderly to pneumonia, presenting a complex interplay of pulmonary …
predisposes the elderly to pneumonia, presenting a complex interplay of pulmonary …